Prediction of Alzheimer's disease using the CSF Aβ42/Aβ40 ratio in patients with mild cognitive impairment
In: Dementia and geriatric cognitive disorders, Jg. 23 (2007), Heft 5, S. 316-320
Online
academicJournal
- print, 24 ref
Zugriff:
Evidence supports an important role for β-amyloid (Aβ) in the pathogenesis of Alzheimer's disease (AD). Here, we investigate baseline levels of the 40- and 42-amino-acid-long Aβ peptides (Aβ40 and Aβ42) in cerebrospinal fluid (CSF) from a cohort of patients with mild cognitive impairment (MCI, n = 137) in relation to the final diagnosis after 4-6 years of follow-up time. CSF Aβ42 concentration at baseline and the Aβ42/Aβ40 ratio were significantly decreased in the MCI patients who developed AD as compared to cognitively stable MCI patients and MCI patients who developed other forms of dementia (p < 0.001). The baseline levels of Aβ40 were similar in all MCI groups but correlated with change in Mini Mental State Examination scores in converters to AD. The Aβ42/Aβ40 ratio was superior to Aβ42 concentration with regard to identifying incipient AD in MCI (p < 0.05). In conclusion, the data provide further support for the view that amyloid precursor protein metabolism is disturbed in early sporadic AD and points to the usefulness of the Aβ42/ Aβ40 ratio as a predictive biomarker for AD.
Titel: |
Prediction of Alzheimer's disease using the CSF Aβ42/Aβ40 ratio in patients with mild cognitive impairment
|
---|---|
Autor/in / Beteiligte Person: | HANSSON, Oskar ; ZETTERBERG, Henrik ; BUCHHAVE, Peder ; ANDREASSON, Ulf ; LONDOS, Elisabet ; MINTHON, Lennart ; BLENNOW, Kaj |
Link: | |
Zeitschrift: | Dementia and geriatric cognitive disorders, Jg. 23 (2007), Heft 5, S. 316-320 |
Veröffentlichung: | Basel: Karger, 2007 |
Medientyp: | academicJournal |
Umfang: | print, 24 ref |
ISSN: | 1420-8008 (print) |
Schlagwort: |
|
Sonstiges: |
|